The results revealed a significant increase in the number of TLR4+CD14++CD16+CCR2+ monocytes in NSTEMI patients compared with CAD patients, and the number of TLR4+CD14++CD16+CCR2+ was positively correlated with the plasma interleukin-6 (IL-6) level. This evidence concerns the gene CD14 and coronary artery disorder.